London and Oxford, UK, 15 May 2023 – Self funded, not-for-profit medical research organisation LifeArc and techbio company PrecisionLife announce a strategic R&D collaboration to accelerate the discovery and development of targeted treatments for motor neuron disease (MND) - also known as amyotrophic lateral sclerosis (ALS), and Lou Gehrig's disease.
News
- First delivery and use of DNA manufactured using Evonetix's unique thermally controlled synthesis technology
- Key milestone in the development of Evonetix's desktop DNA synthesis platform
The go-to-market strategies deployed by emerging biotechs to launch their first products into Europe have changed in the last two years.
Instead of building their own infrastructure, emerging biotechs are primarily commercialising their products through out-licencing, partnerships or global biopharma buy-outs.
To hear more about the findings, please read the latest report by the Deloitte Life Sciences Catalyst team.
Source LDPath’s outstanding digital integration with East Kent Hospital NHS Foundation Trust (EKHUFT) pathology department has been selected as the winner of the “Best Hospital Technology Implementation” award in the 7th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough.
o2h group, the creators of innovative SciTech communities, has launched the Cambridge Wide Open Day, offering a unique insight into the city best known as the ‘UK Centre of Science & Technology’. The inaugural event will take place on Wednesday 14 June 2023, welcoming science enthusiasts and local residents alike from across the Cambridge community – giving everyone the opportunity to explore the city’s world-class science and technology facilities all in one day.
Howard Group appoints Jon Green as Director – Unity Campus Experienced life sciences executive and site leader to take on the role from June this year |
April 2023 marks five years since Medicines Discovery Catapult (MDC), an independent, not-for-profit national innovation centre for drug discovery, actively began reshaping drug discovery for patient benefit.
To mark this milestone, MDC has launched an impact showcase site, offering an immersive insight into a selection of MDC's work through the lens of its collaborations and initiatives.
In a move that will build on its leading position in the market and bring together experts across the business, Partners& has launched a national science and technology practice.
In line with the UK government’s commitment to focusing on the growth and development of this important part of our economy, Partners& is positioning itself to deliver a unique proposition to this complex, fast moving and innovative sector.
Check out your monthly round up of employee engagement opportunities in this month's People Pathways newsletter!